Elevated levels of the EGF receptor (EGFR) have correlated to poor prognosis in head and neck, ovarian, cervical, bladder and oesophageal cancers [49] but substantial similar data for melanoma is not yet available. This evidence concerns the gene EGFR and carcinoma of esophagus.